Trials / Sponsors / Nacuity Pharmaceuticals, Inc.
Nacuity Pharmaceuticals, Inc.
Industry · 4 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | 24-Month Trial of NPI-001 for the Preservation of Photoreceptors in Retinitis Pigmentosa Associated With Usher Retinitis Pigmentosa (RP), Usher Syndrome | Phase 3 | 2026-06-01 |
| Recruiting | PK and PD Study of NPI-001 and Cysteamine Bitartrate Cystinosis | Phase 1 / Phase 2 | 2023-10-29 |
| Active Not Recruiting | NPI-002 Intravitreal Implant for the Delay of Cataract Progression Cataract | Phase 1 / Phase 2 | 2022-01-27 |
| Active Not Recruiting | Safety and Efficacy of NPI-001 Tablets for RP Associated With Usher Syndrome Usher Syndromes | Phase 1 / Phase 2 | 2020-09-03 |